Sociodemographic and clinical characteristics of patients with drug-resistant tuberculosis in Hunan province, 2012–2018
| Variables | No (%) |
| Sex | |
| Male | 1983 (74.86) |
| Female | 666 (25.14) |
| Mean age (years) | 46.54 (SD +15.16) |
| Management organisation | |
| CDC | 2263 (88.09) |
| TB hospital | 306 (11.91) |
| Notification year | |
| 2012 | 177 (6.68) |
| 2013 | 221 (8.34) |
| 2014 | 352 (13.29) |
| 2015 | 375 (14.16) |
| 2016 | 511 (19.29) |
| 2017 | 406 (15.33) |
| 2018 | 607 (22.91) |
| Month of TB registration | |
| January–April | 506 (19.10) |
| May–August | 914 (34.50) |
| September–December | 1229 (46.40) |
| Occupation | |
| Farmer | 1883 (71.08) |
| Government employee | 76 (2.87) |
| Non-government employee | 150 (5.66) |
| Labourer | 74 (2.79) |
| Retired | 108 (4.08) |
| Student | 65 (2.45) |
| Unknown | 113 (4.27) |
| Others | 180 (6.8) |
| Type of DR-TB | |
| RR-TB | 121 (4.57) |
| MDR-TB | 2439 (92.07) |
| XDR-TB | 89 (3.36) |
| History of TB treatment | |
| First-line treatment history | 1371 (51.76) |
| Second-line treatment history | 974 (36.77) |
| No TB treatment history | 304 (11.48) |
| Mode of treatment | |
| Ambulatory | 116 (4.38) |
| Hospitalisation | 1760 (66.44) |
| Not registered | 773 (29.18) |
| Drug sources | |
| GLC | 468 (17.67) |
| China | 1111 (41.94) |
| Both | 178 (6.72) |
| Not registered | 892 (33.67) |
| Treatment outcomes | |
| Completed treatment | 198 (7.47) |
| Cure | 434 (16.38) |
| Failure | 108 (4.08) |
| Lost to follow-up | 455 (17.18) |
| death | 92 (3.47) |
| Unknown | 25 (0.94) |
| Still on treatment | 1337 (50) |
.CDC, The Centres for Disease Control and Prevention; DR-TB, drug-resistant tuberculosis; GLC, green light committee; MDR-TB, multidrug-resistant tuberculosis; RR-TB, rifampicin resistant tuberculosis; TB, tuberculosis; XDR-TB, extensively drug-resistant tuberculosis.